Komori
Medikit (7749) · FactRestated

Single-segment business focused on vascular and blood-related fields

First written in FY2016. 26 of 27 entries say "Restated". Latest entry: FY2026-H1.

27entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2026-H12016: 320162017: 320172018: 420182019: 320192020: 220202021: 420212022: 420222023: 220232024: 120242025: 12025
Same theme, other companies
Single-segment structure focused on medical devices in the vascular and blood-related fieldsA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  2. FY2024-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  3. FY2024-Q1RestatedAnnual report

    「In addition, as our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  4. FY2023-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  5. FY2023-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  6. FY2023-Q1RestatedAnnual report

    「In addition, as our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business has been reaffirmed.
  7. FY2022RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported in the annual report.
  8. FY2022-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  9. FY2022-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  10. FY2022-Q1RestatedAnnual report

    「In addition, as our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  11. FY2021RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  12. FY2021-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  13. FY2021-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  14. FY2020-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  15. FY2020-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  16. FY2020-Q1RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  17. FY2019-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  18. FY2019-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  19. FY2019-Q1RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  20. FY2018RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues.
  21. FY2018-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  22. FY2018-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  23. FY2018-Q1RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  24. FY2017-Q3RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  25. FY2017-Q2RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  26. FY2017-Q1RestatedAnnual report

    「As our group operates a single segment comprising the manufacture and sale of medical devices, segment information has been omitted.」

    The single-segment structure comprising the medical device manufacturing and sales business continues to be reported.
  27. FY2016First statedAnnual report

    「Our group primarily handles medical devices in the vascular and blood-related fields. As we operate a single segment, the products are classified as follows.」

    A single segment centered on 3 product categories: hemodialysis products, indwelling venous needles, including anesthesia-related products, and angiography products.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.